Published: 21 Jan 2026 107 views
The Department of Pediatric Hematology and Oncology, Center for Pediatrics (medical director: Prof. T. Feuchtinger) has an opening in the field of novel cell, immune and gene therapies starting in Q1 2026 for a PhD candidate (Biology, Biochemistry, Molecular Medicine or related).
The University of Freiburg is seeking candidates with an interest in cancer immunology and pediatric oncology to conduct comprehensive in vitro and in vivo functional testing for prevention of immune escape. The available PhD project aims to investigate immune escape mechanisms of pediatric leukemias in the context of modern immunotherapies, particularly CAR T-cell therapies. The goal is to understand the biological basis of therapy-resistant relapses and to translate these findings into new, clinically relevant treatment strategies.
Methodological focus:
Check also:
2026 Fully Funded Humboldt Research Fellowship
2026 Konrad Adenauer Foundation Scholarship
Contact: [email protected]
For more information, kindly visit University of Freiburg webpage.
A friend or someone might be interested in this opportunity, kindly share.